Everything You Need to Know About Fat-soluble vitamins (A, D, E, K) for Step 1

Fat-soluble vitamins are classic Step 1 “gotcha” territory: they’re absorbed with dietary fat, stored in the body (so toxicity is real), and deficiencies show up in predictable organ systems (eyes, bones, nerves, coagulation). If you can tie each vitamin to its key biochemical role → risk factors for deficiency → hallmark symptoms → best test → treatment/toxicity, you’ll crush a whole category of questions.

---

Big Picture: What Makes Vitamins A, D, E, K “Fat-Soluble”?

Core concept: Fat-soluble vitamins require bile acids and pancreatic enzymes for absorption in the small intestine and are transported in chylomicrons.

High-yield implications

• Deficiency risks increase with fat malabsorption, including:
  • Cholestasis/obstructive jaundice (no bile → no micelles)
  • Pancreatic insufficiency (e.g., cystic fibrosis, chronic pancreatitis)
  • Celiac disease, Crohn disease (esp. ileal)
  • Bariatric surgery (esp. bypass procedures)
  • Orlistat (fat absorption inhibitor)
• Toxicity is more likely than with water-soluble vitamins because these are stored (liver/adipose).

Quick absorption & storage table (Step-friendly)

First Aid cross-ref: Biochemistry → Vitamins; GI → Malabsorption; Heme/Onc → Coagulation pathways (vit K); MSK/Endo → Bone metabolism (vit D).

---

Vitamin A (Retinol): Vision, Epithelium, Immunity

Definition & functions

Vitamin A includes:

• Retinol (storage/transport form)
• Retinal (vision—rhodopsin)
• Retinoic acid (gene transcription, epithelial differentiation)

High-yield roles

• Vision (especially night vision): 11-cis-retinal combines with opsin → rhodopsin
• Epithelial differentiation: maintains mucosal surfaces (resp/GI/GU)
• Immune function: supports barrier + immune signaling

Pathophysiology of deficiency

Low vitamin A → impaired rhodopsin regeneration + impaired epithelial differentiation → xerosis and keratinization, higher infection risk.

Clinical presentation (classic Step findings)

• Night blindness (nyctalopia) = early clue
• Xerophthalmia (dry eyes), Bitot spots (foamy plaques on conjunctiva)
• Keratomalacia (corneal softening) → blindness
• Follicular hyperkeratosis (“gooseflesh” skin)
• Increased susceptibility to infections (esp. measles severity)

Diagnosis (what NBME likes)

• Often clinical in the right context (malnutrition, malabsorption)
• Low serum retinol may support diagnosis (not always needed for exam logic)

Treatment

• Vitamin A supplementation
• Address underlying cause (e.g., treat cholestasis/malabsorption)
• In measles: vitamin A supplementation reduces morbidity (a common board association)

Toxicity (very high yield)

Usually from supplements (not food).

• Acute toxicity: nausea, vomiting, vertigo, blurred vision, increased ICP
• Chronic toxicity:
  • Hepatotoxicity
  • Alopecia, dry skin
  • Bone pain
  • Pseudotumor cerebri (increased ICP)
• Teratogenicity: retinoids (e.g., isotretinoin) → severe fetal defects

First Aid cross-ref: Derm → Retinoids (isotretinoin); Biochem → Vitamin A deficiency/toxicity; Neuro → Increased intracranial pressure.

HY association: Zinc deficiency can mimic vitamin A issues because zinc is needed for retinol-binding protein synthesis and retinal metabolism (Step 1 loves “indirect deficiency”).

---

Vitamin D (Cholecalciferol/Ergocalciferol): Calcium & Phosphate Homeostasis

Definition & synthesis pathway (must-know)

Vitamin D sources:

• D3 (cholecalciferol): skin (UVB converts 7-dehydrocholesterol) + animal diet
• D2 (ergocalciferol): plant sources

Activation steps:

1. Liver: vitamin D → 25-hydroxyvitamin D (calcidiol)
2. Kidney (proximal tubule): 25-OH D → 1,25-dihydroxyvitamin D (calcitriol) via 1α-hydroxylase

Regulation of 1α-hydroxylase

• Upregulated by: PTH, low phosphate
• Downregulated by: high phosphate, high calcium, FGF23

Physiology (what it does)

Calcitriol increases:

• Intestinal absorption of Ca²⁺ and PO₄³⁻
• Bone mineralization (at physiologic levels)
• Can increase bone resorption indirectly when needed (via RANKL signaling in severe deficiency/high PTH states)

Deficiency: pathophysiology

Low vitamin D → decreased Ca/PO₄ absorption → secondary hyperparathyroidism → bone demineralization.

Common causes

• Low sunlight exposure
• Darker skin (reduced UVB penetration)
• Malabsorption (cholestasis, CF)
• Chronic kidney disease (↓ 1α-hydroxylation)
• Liver disease (↓ 25-hydroxylation)

Clinical presentation

• Rickets (children):
  • Delayed closure of fontanelles
  • Bowed legs
  • Rachitic rosary (costochondral swelling)
• Osteomalacia (adults):
  • Bone pain, fragility fractures
  • Proximal muscle weakness

Diagnosis (exam-style)

• Best screening marker of vitamin D stores: 25-hydroxyvitamin D
• Expected labs in deficiency (classic pattern):
  • ↓ 25-OH D
  • ↓ or normal Ca²⁺ (often low-normal early)
  • ↓ phosphate
  • ↑ PTH
  • ↑ alkaline phosphatase

Treatment

• Vitamin D supplementation (D2 or D3)
• Add calcium if needed
• In CKD: consider calcitriol (active form) or analogs, plus phosphate management

Toxicity (boards love the consequence)

Usually from excessive supplementation:

• Hypercalcemia → stones, bones, groans, psychiatric overtones
• Polyuria, dehydration
• Can cause soft tissue calcification

First Aid cross-ref: Renal → CKD mineral bone disease; Endo → PTH regulation; MSK → Rickets/osteomalacia.

---

Vitamin E (α-Tocopherol): Antioxidant & RBC/Neuronal Protection

Definition & function

Vitamin E is a major antioxidant that protects cell membranes from oxidative damage by preventing lipid peroxidation.

Where it matters most

• RBC membranes (prevent hemolysis)
• Neurons (long axons are sensitive to oxidative injury)

Deficiency: pathophysiology

Often due to fat malabsorption or impaired lipoprotein assembly/transport:

• Cystic fibrosis (pancreatic insufficiency)
• Cholestasis
• Abetalipoproteinemia (can’t form ApoB-containing lipoproteins → can’t transport fat-soluble vitamins)

Clinical presentation (high yield)

• Hemolytic anemia (especially in premature infants)
• Acanthocytosis (spur cells) classically in abetalipoproteinemia
• Neurologic deficits:
  • Peripheral neuropathy
  • Ataxia
  • Loss of vibration/proprioception (posterior columns)

Diagnosis

• Clinical + risk factors; low serum α-tocopherol may be used
• Hemolysis markers if anemia present (↑ LDH, ↑ indirect bilirubin, ↓ haptoglobin)

Treatment

• Vitamin E supplementation
• Treat the underlying malabsorption issue

First Aid cross-ref: Biochem → Vitamin E deficiency; GI → Abetalipoproteinemia; Heme → Hemolytic anemia patterns.

HY association: Abetalipoproteinemia presents with fat malabsorption, steatorrhea, failure to thrive, neurologic symptoms, acanthocytes, and deficiencies of A, D, E, K—vitamin E-related neuro findings often stand out.

---

Vitamin K: γ-Carboxylation for Clotting

Definition & function

Vitamin K is a cofactor for γ-glutamyl carboxylase, which γ-carboxylates glutamate residues on clotting proteins, enabling them to bind calcium and function properly.

Vitamin K–dependent proteins

• II, VII, IX, X
• Protein C and Protein S

Pathophysiology of deficiency

Without vitamin K → impaired activation of clotting factors → bleeding tendency.

Who gets deficient? (classic Step scenarios)

• Newborns (sterile gut + low vitamin K in breast milk) → hemorrhagic disease of the newborn
• Broad-spectrum antibiotics (wipe out gut flora)
• Fat malabsorption (cholestasis, CF)
• Warfarin therapy (vitamin K antagonist)

Clinical presentation

• Easy bruising, mucosal bleeding, GI bleeding
• Oozing from venipuncture sites
• In newborns: intracranial hemorrhage risk

Diagnosis: the coag labs you must interpret

• Increased PT/INR (factor VII has the shortest half-life → PT rises first)
• If severe: can also prolong aPTT (due to IX, X, II)
• Platelets are typically normal (this is not thrombocytopenia)

PT vs PTT high-yield table

Treatment

• Vitamin K (phytonadione) for deficiency
• In serious bleeding or warfarin-associated major bleed: PCC (prothrombin complex concentrate) ± FFP, plus vitamin K
• Newborn prophylaxis: vitamin K injection at birth

Warfarin tie-in (Step 1 classic)

• Warfarin inhibits vitamin K epoxide reductase → decreases activation of II, VII, IX, X, C, S
• Early warfarin therapy can cause transient hypercoagulability due to Protein C drop → “warfarin skin necrosis” (heparin bridge in high-risk patients)

First Aid cross-ref: Pharm → Anticoagulants (warfarin, heparin, PCC/FFP); Biochem → Vitamin K; Peds → Newborn prophylaxis.

---

Putting It Together: Rapid Fire High-Yield Comparison

---

Test-Day Patterns (How NBME Writes These)

Pattern 1: Cholestasis → multiple deficiencies

A patient with pale stools, dark urine, pruritus → cholestasis → can’t absorb fat → deficiencies in A, D, E, K:

• Night blindness (A)
• Bone pain/fractures (D)
• Ataxia/hemolysis (E)
• Easy bruising and ↑ PT (K)

Pattern 2: Broad-spectrum antibiotics → bleeding

Antibiotics wipe gut flora → ↓ vitamin K production → ↑ PT/INR. Treat with vitamin K.

Pattern 3: Newborn bleed prevention

Newborn with bleeding or to prevent it → vitamin K injection at birth.

Pattern 4: Warfarin affects PT first

Warfarin patient with elevated INR: remember factor VII drops quickly → PT increases first.

---

Mini “First Aid Map” (What to flip to while studying)

• Biochemistry
  • Vitamins A, D, E, K: functions, deficiency, toxicity
• GI
  • Fat malabsorption syndromes (cholestasis, CF, celiac)
• Renal/Endocrine
  • Vitamin D activation (liver/kidney), PTH regulation
• Heme/Onc
  • Coagulation cascade, PT/INR interpretation, factor half-lives
• Pharmacology
  • Warfarin mechanism, reversal (vit K, PCC/FFP), heparin bridge

---

Quick Self-Check (1-minute drill)

• Night blindness + dry eyes → A deficiency
• Bone pain + ↑ ALP + ↑ PTH → D deficiency
• Hemolysis + neuro deficits in malabsorption → E deficiency
• ↑ PT/INR after antibiotics or in newborn → K deficiency
• Toxicity worries (stored vitamins) → A and D lead the pack